Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
about
Can exercise increase fitness and reduce weight in patients with schizophrenia and depression?Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approachSafety and tolerability of antipsychotic polypharmacy.A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsMetabolic syndrome in schizophrenia.Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study.Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity."First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects.Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany.Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study.Oral Hygiene - A Challenge in Everyday Life for People with Schizophrenia.Outreach visits by clinical pharmacists improve screening for the metabolic syndrome among mentally ill patients.Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.
P2860
Q27023984-64329783-2758-4F21-B1F1-4359A4AE5399Q34464293-0DE965B5-DE84-4BEC-9D97-67651FE6492CQ36062421-4B137E2E-F781-46A6-A133-124F787CAB93Q37236162-1B2B272A-C839-4E48-B015-B223B95BEF46Q37290165-40DC9B9A-CE6F-4C7A-8690-8563CC2E018CQ37682840-0B875555-81D0-43E4-B031-BCABB1CB1403Q37684797-07F7E55C-ACBD-48CA-BCDD-D42E8E83303EQ38176982-D90F3811-D71C-431B-B9C1-FCBC74E879FAQ38254745-0F02AF50-C247-4717-9A47-C63B005211AFQ38291338-35A3267D-5EB7-4328-8863-39128B8445B0Q39353717-7210C6D4-FBF5-45A3-AC4E-736904A72BF9Q39684713-B93AE7E6-E579-492C-B347-10A24E55738CQ44066171-2B8F3325-05DD-404F-91FF-A85D16BA6BD3Q46158848-D372FD78-E571-4E39-AA6C-6B6C7F3B8034Q48177093-07CA151D-D744-4F4B-B363-E5902553EF25Q50898947-42D31E48-49E0-449D-B30F-4EBB195D1540Q50973671-6B3CE4FB-1C8B-48F4-9E85-1D83811A6D1FQ51244179-B09E0B3D-7776-45FC-ADA8-EF9F63B51FC5
P2860
Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@en
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@nl
type
label
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@en
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@nl
prefLabel
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@en
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@nl
P2093
P2860
P1476
Prevalence of the metabolic sy ...... s treated with antipsychotics.
@en
P2093
Anne Køster
Charlotte Glümrr
Karoline Krane-Gartiser
Leif Breum
Maiken Madsen
Peter W Jepsen
P2860
P304
P356
10.3109/08039488.2011.565799
P577
2011-03-24T00:00:00Z